Sublocade Cost in Michigan: What You’ll Pay With and Without Insurance
Sublocade cost in Michigan is significant if you’re thinking about this monthly injection to treat opioid use disorder. The list price stands at $2,202.03 per month, but what you pay varies. Almost 90% of people with Medicaid pay $0. Those without insurance face the full list price. We’ve created this piece to help you understand how much Sublocade costs based on your insurance situation. You’ll also learn what financial assistance programs are available and where to find certified providers in Michigan who can administer this treatment.
What is Sublocade and How Does It Work?
Buprenorphine Extended-Release Injection
Sublocade is an FDA-approved extended-release buprenorphine injection indicated for treating moderate to severe opioid use disorder. The medication contains buprenorphine, a partial opioid agonist, and is administered as a monthly subcutaneous injection. Patients must first undergo induction and stabilization with a transmucosal buprenorphine product. This delivers the equivalent of 8-24 mg/day for a minimum of 7 days before starting Sublocade.
The formulation uses a poly(lactide-co-glycolide) (PLGA)-based system that transforms into a solid depot after injection. The medication reacts with body fluids to form a semi-solid mass when administered subcutaneously. This mass slowly breaks down over the following month and steadily releases buprenorphine into the bloodstream. Healthcare providers can administer Sublocade in the abdomen, thigh, buttock, or back of the upper arm.
Sublocade should be used as part of a complete treatment program that has counseling and psychosocial support. Patients not currently taking buprenorphine receive an original dose of transmucosal buprenorphine before their first injection to confirm tolerability.
Monthly Dosing: 300mg and 100mg Options
The recommended dosing protocol starts with two monthly original doses of 300 mg, followed by 100 mg monthly maintenance doses. Sublocade comes in single-use syringes at two dosage strengths: 300 mg in 1.5 mL and 100 mg in 0.5 mL. The second injection can be administered as early as 1 week and up to 1 month after the original injection, based on patient need. Getting the second shot as early as 1 week after the first may help Sublocade build up in the body faster.
Patients on long-term treatment with 8-18 mg/day of transmucosal buprenorphine may reduce their dose to 100 mg at the second injection if opioid withdrawal and cravings are controlled. Maintenance doses should be administered with at least 26 days between injections.
The maintenance dose can be increased to 300 mg monthly for patients who tolerate the 100 mg dose but fail to show a satisfactory clinical response. Ground data shows that nearly 48% of patients received at least one 300 mg maintenance dose following their two original 300 mg doses. Steady-state buprenorphine plasma levels are achieved after 4-6 monthly injections.
How Sublocade Reduces Opioid Cravings
Buprenorphine acts as a partial agonist at the mu receptor, which means it partially activates mu-opioid receptors. It reduces the need for opioids without producing the same euphoric feeling since it doesn’t stimulate these receptors as much as full opioid agonists like heroin or morphine. Buprenorphine also blocks kappa opioid receptors and prevents other opioids from acting on these receptors if taken during treatment.
The partial agonist mechanism creates a ceiling effect on respiratory depression and provides a safety advantage over full agonists. Sublocade blocks other opioids from producing euphoria by maintaining steady buprenorphine levels in the brain’s mu receptors throughout the month. This continuous delivery eliminates daily medication ups and downs.
28% of patients on Sublocade plus counseling achieved treatment success compared to 2% on placebo plus counseling in clinical trials. More, monthly extended-release buprenorphine showed superiority over daily sublingual formulations, with 7.6% symptom recurrence versus 27.6%, and 48% fewer emergency visits among adherent patients.
Sublocade Cost With Commercial Insurance in Michigan
Average Out-of-Pocket Costs for Private Insurance
Commercial insurance reduces Sublocade cost in Michigan by a lot compared to paying the full list price. Out-of-pocket expenses with private insurance range from $0.01 to $1,822 per month. The average out-of-pocket cost sits at $243, though some sources report an average of $402. This wide variation stems from differences in plan design, deductibles and coinsurance rates across insurance carriers.
Coverage statistics show promise for Michigan patients seeking treatment. Research shows that 88% of people who have insurance have coverage for Sublocade. Private insurance plans obtained through employers or purchased on your own follow federal regulations like the Affordable Care Act, which influences their coverage policies for medication-assisted treatment.
INSUPPORT Copay Assistance Program: $0 for 95% of Patients
The manufacturer offers substantial financial relief through the INSUPPORT Copay Assistance Program. Eligible patients may pay as little as $0 per injection of Sublocade. Furthermore, 95% of people enrolled in the SUBLOCADE Copay Assistance Program pay $0.
You must meet specific criteria to qualify for copay assistance. The program is valid only for patients with private insurance who are prescribed Sublocade for on-label use. You must be between 18 and 65 years old, reside in the United States or a U.S. territory and live in a state that accepts copay assistance. Your insurance plan must cover some portion of your medication’s cost and not prohibit coupons or copay assistance.
Note that patients with government insurance cannot access this program. This includes those on Medicare, Medicaid, Medigap, VA, DoD, TRICARE or CHAMPVA. The program benefit covers only the out-of-pocket cost for Sublocade itself, not associated costs like office visits or medication administration charges. Patients must enroll themselves by visiting the INSUPPORT website. Upon enrollment, they receive a Copay Member ID card.
Insurance Providers Covering Sublocade in Michigan
Major insurance carriers in Michigan provide coverage for Sublocade. Aetna considers this medication medically necessary for people who are stable in recovery after using a medication like Suboxone. Coverage varies between plans and states. Call the number on your insurance card to confirm your specific benefits.
Prior Authorization Requirements
Most commercial insurance plans require prior authorization before covering Sublocade. This process involves your insurance company and doctor discussing your treatment needs before the insurer determines whether the medication will be covered. Starting treatment without obtaining prior authorization could result in paying the full cost of the medication.
UnitedHealthcare implemented notification and prior authorization requirements beginning July 1, 2018, for commercial plan members. Empire HealthPlus added prior authorization requirements effective February 1, 2019. Failure to complete this process prior to administering Sublocade results in claims denial, and members cannot be billed for the service.
The specialty pharmacy contacts your healthcare provider’s office regarding the authorization submission process and required information when prior authorization is required. Your healthcare provider must complete and submit the PA forms to your insurance provider.
What You’ll Pay With Medicaid and Medicare in Michigan
Government insurance programs offer different cost structures for Sublocade treatment in Michigan. Medicaid and Medicare each have distinct coverage rules. Understanding these differences helps you estimate your actual monthly expenses.
Medicaid Coverage: $1-$3 Average Monthly Cost
Michigan Medicaid patients receive substantial cost protection for Sublocade. Almost 90% of people with Medicaid pay $0.00. The vast majority of the remaining people on Medicaid pay $1.00-$4.00 per month. State Medicaid programs determine your specific health plan and costs. Coverage can vary based on your state formulary (the list of covered drugs).
Most patients with Medicaid pay low or no cost for Sublocade if it is a preferred drug treatment by their state health plan. You may need to meet specific criteria or have used other treatments first without success before you are eligible to receive Sublocade. Check with your doctor about whether Michigan Medicaid covers Sublocade. This provides clarity on your eligibility. You can also search online for a formulary list of preferred Medicaid drugs in your state.
Medicare Part B and Part C Coverage
Medicare covers Sublocade under specific conditions based on the plan type you hold. Medicare Part B covers medications administered by a healthcare provider, while Medicare Part D covers prescription drugs. Sublocade is an injection given by a medical professional, so Part B covers it. Traditional Medicare covers these medications for beneficiaries who have Medicare Part B coverage. These medications must be ‘incident to’ a physician’s professional service.
Medicare Advantage (MA) plans, also known as Part C, must cover these medications to treat addiction. Under CFR §422.100(a), MA plans must provide the same ‘basic benefits’ to beneficiaries in MA plans that are available under traditional Medicare. Traditional Part B covers these medications, so MA plans must cover them under MA. But prior authorization and specific eligibility criteria may apply.
Medicare Out-of-Pocket Range: $0.02 to $1,607
Medicare patients face a wider cost range than those with Medicaid. You could pay between $0.02 to $1,607.00 per dose (whether 300 mg or 100 mg) if you are receiving Sublocade once monthly (depending on your specific Medicare benefits). The average out-of-pocket cost of Sublocade itself is $97.00.
Traditional Medicare and MA plans may impose utilization management on these medications, including prior authorization. CMS states that it would not approve MA plans that require prior authorization more than once per year in 2019 guidance to MA plans. On top of that, some plans may subject beneficiaries to cost-sharing such as co-pays.
Supplemental Insurance Options for Medicare Patients
Many people overlook this: additional insurance layers can reduce your Medicare costs substantially. You may also have a supplemental insurance plan that will pay all or part of your Sublocade costs if you have Medicare Part B. Medicare Part C has an out-of-pocket maximum. What you will pay for Sublocade depends on your plan’s benefit design and the level of other healthcare expenses you have during the year.
Sublocade Cost Without Insurance: List Price and Payment Options
Paying out-of-pocket presents the most important financial challenge for Michigan residents without insurance coverage. The actual cost varies slightly depending on the source, but expect to face substantial monthly expenses.
List Price: $2,117 to $2,202 Per Dose
You can expect to pay the list price for Sublocade without insurance. The wholesale acquisition cost (WAC) in the U.S. is $2,202.03 per monthly dose as of January 1, 2026, for both the 100 mg and 300 mg dosage forms. Another source lists the cost at $2,117.34. Most people will not pay this full amount though.
Almost 9% of people in the United States didn’t have health insurance at any point in the year back in 2020. The list price represents a substantial barrier for uninsured patients. This cost covers only the medication itself and not office visits, counseling services, or administration charges that accompany treatment.
Patient Assistance Programs Available
Patient assistance programs exist to help reduce costs for those without coverage. The manufacturer offers support options, though limitations apply. The INSUPPORT Copay Assistance Program remains unavailable to uninsured patients since it requires private insurance coverage for eligibility. This program helps only those with commercial insurance plans and not individuals paying out-of-pocket.
Payment Plans Through Treatment Providers
Talk with your doctor about other savings programs or payment plans that may be available if you lack insurance. Many treatment providers structure their own payment arrangements to make medication-assisted treatment more available. Contacting providers about their financial options becomes necessary.
Some facilities offer specific assistance. ReVIDA Recovery, to name just one example, provides scholarships to Tennessee residents who can’t afford treatment and pairs patients with care coordinators who help develop payment plans. This example comes from Tennessee, but similar provider-based programs may exist at Michigan treatment centers.
Michigan-Specific Financial Support Resources
Finding Michigan-specific financial support requires direct outreach to local treatment centers and state resources. Contact Michigan substance abuse treatment facilities to ask about sliding scale fees, internal assistance funds, or connections to charitable organizations supporting addiction treatment costs. Healthcare providers often maintain relationships with local foundations or nonprofit groups that assist patients facing financial barriers to medication-assisted treatment.
Finding Sublocade Treatment Providers in Michigan
You need to understand certification requirements and verify insurance acceptance before you can find qualified providers who administer Sublocade.
REMS-Certified Healthcare Providers
Sublocade operates under a Risk Evaluation and Mitigation Strategy (REMS) program that prevents serious harm from intravenous self-administration. Healthcare providers do not need REMS certification to prescribe Sublocade. You can receive treatment from physicians and nurse practitioners who have legal permissions to treat opioid dependence with FDA-approved medications.
Prescribers write a prescription and send it to a REMS-certified pharmacy. The pharmacy coordinates delivery to the administering practitioner with your appointment date. Healthcare settings that keep a supply of SUBLOCADE in stock and order from distributors must be certified in the SUBLOCADE REMS before purchasing the medication. Pharmacies that stock Sublocade must maintain REMS certification as well. Retail pharmacies do not carry Sublocade.
Michigan Treatment Centers Accepting Sublocade Patients
The Find a SUBLOCADE Treatment Provider Tool on SUBLOCADE.com helps locate qualified providers. This free tool lists physicians and nurse practitioners who have prescribed SUBLOCADE at least once in the previous two years and agreed to be included. Enter your ZIP code and select your preferred search radius to find nearby providers.
Questions About Insurance Acceptance
Contact potential providers to verify they accept your insurance and understand your financial obligations. Ask these questions:
- Do you accept my insurance plan for Sublocade treatment?
- Are you an in-network or out-of-network provider with my plan?
- What prior authorization requirements apply to my coverage?
- What will my cost-sharing obligations be, including copays and deductibles?
- Does your office handle benefits investigation to determine my out-of-pocket costs?
Verify coverage details with both the provider and your insurance company. Plan directories are often inaccurate and out-of-date.
Find Treatment Today
We’ve covered the complete cost breakdown for Sublocade treatment in Michigan in all insurance scenarios. The list price of $2,202.03 per month might seem overwhelming at first, but financial relief is available. 95% of patients with commercial insurance pay $0 through the INSUPPORT copay assistance program, while nearly 90% of Medicaid recipients also pay nothing.
Your next step: contact REMS-certified providers using the finder tool we mentioned and verify your insurance coverage. Ask about prior authorization requirements. Payment assistance programs exist to make treatment available whatever your insurance situation.